# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA687640 | F | Cytotoxic dose required to reduce the viability of normal uninfected MT-4 cells. | Homo sapiens | 29 | ALA1124230 | cell-based format | Scientific Literature | |
2. | ALA694656 | F | Tested in vitro against MT-4 cells using MTT assay | Homo sapiens | 21 | ALA1133528 | cell-based format | Scientific Literature | |
3. | ALA698918 | F | Cytotoxic dose required to inhibit HIV-induced cytopathogenicity in human MT-4 cells | Homo sapiens | 5 | ALA1124551 | cell-based format | Scientific Literature | |
4. | ALA696399 | F | Effective dose required to inhibit HIV-induced cytopathogenicity in human MT-4 cells | Homo sapiens | 5 | ALA1124551 | cell-based format | Scientific Literature | |
5. | ALA697216 | F | Concentration required to reduce the viability of Human T-lymphoblast MT-4 cells | Homo sapiens | 4 | ALA1125587 | cell-based format | Scientific Literature | |
6. | ALA712341 | F | Effective concentration to achieve 50% protection of MT-4 cells against the cytopathic effect of HIV-1 | 28 | ALA1126896 | cell-based format | Scientific Literature | ||
7. | ALA712342 | F | Effective concentration to achieve 50% protection of MT-4 cells against the cytopathic effect of HIV-2 | 28 | ALA1126896 | cell-based format | Scientific Literature | ||
8. | ALA879738 | F | Effective concentration of compound required to reduce the cytopathic effect of HIV-1 IIIB in MT-4 cells by 50% | Homo sapiens | 8 | ALA1132736 | cell-based format | Scientific Literature | |
9. | ALA712343 | F | Effective concentration of compound required to reduce the cytopathic effect of HIV-2ROD in MT-4 cells by 50% | Homo sapiens | 8 | ALA1132736 | cell-based format | Scientific Literature | |
10. | ALA712345 | F | Effective concentration required to achieve 50% protection of MT-4 cells against the cytopathic effect of HIV-1 | Homo sapiens | 7 | ALA1126533 | cell-based format | Scientific Literature | |
11. | ALA712347 | F | Effective concentration required to inhibit HIV-1-induced cytopathicity in MT-4 cells | Homo sapiens | 4 | ALA1126103 | cell-based format | Scientific Literature | |
12. | ALA712352 | F | In vitro inhibition of cytopathic effect was determined against HIV-1 IIIB in MT-4 cells using MTS cytoprotection assay | Homo sapiens | 1 | ALA1134356 | cell-based format | Scientific Literature | |
13. | ALA712353 | F | Inhibition of HIV-1 (strain A17)-infected MT-4 cells | Homo sapiens | 1 | ALA1127033 | cell-based format | Scientific Literature | |
14. | ALA712354 | F | Inhibition of cytopathic effect of HIV-1 in MT-4 cells | Homo sapiens | 13 | ALA1126855 | cell-based format | Scientific Literature | |
15. | ALA712355 | F | Inhibition of cytopathic effect of HIV-1 strain RF in MT-4 cell culture | Homo sapiens | 1 | ALA1126854 | cell-based format | Scientific Literature | |
16. | ALA712356 | F | Inhibition of cytopathic effect of HIV-1 strain RF in MT-4 cell culture | 34 | ALA1126854 | cell-based format | Scientific Literature | ||
17. | ALA712358 | F | Inhibitory activity against HIV-1 IIIB in MT-4 infected cells | Homo sapiens | 1 | ALA1132068 | cell-based format | Scientific Literature | |
18. | ALA712359 | F | Inhibitory activity toward HIV replication in MT-4 cells | Homo sapiens | 1 | ALA1126217 | cell-based format | Scientific Literature | |
19. | ALA879739 | F | Tested for cytotoxic concentration required to reduce the viability of MT-4 cells by 50% | Homo sapiens | 6 | ALA1135216 | cell-based format | Scientific Literature | |
20. | ALA884419 | F | Tested for effective concentration required to protect MT-4 cells against the cytopathicity of HIV-1(IIIB) | Homo sapiens | 1 | ALA1135216 | cell-based format | Scientific Literature |